The World Health Organization’s Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector was established in 2015 at the Leslie Dan Faculty of Pharmacy is charged with conducting research, analysis, and training on critical issues related to good governance and transparency in medicines.
Led by Professor Jillian Kohler, a recognized global expert on corruption and governance in the pharmaceutical system, the WHO-CC at the Faculty of Pharmacy, assembles leading governance and related experts on a shared research and education agenda. They have created a collaborative network to support WHO policy and country operations on the global wicked problem of corruption.
The WHO CC is focused squarely on identifying practical ways to address a lack of good governance in the pharmaceutical system, that create opportunities for corruption to emerge, at any point within the pharmaceutical system from research and development to service delivery and at any level of government. Corruption, defined by Transparency International is, “the misuse of entrusted power for private gain.” It is a well-known threat to development, economic growth and thwarts efforts to improve global access to medicines.
Leveraging the strengths of researchers at the University of Toronto and throughout the Americas, the Centre draws on the expertise of its fellows and parters to implement a comprehensive research and training program, which is informing the programmatic work of the WHO and governments.
Members include Research Fellows from:
- Leslie Dan Faculty of Pharmacy
- Dalla Lana School of Public Health
- The Munk School of Global Affairs
- Rotman School of Management at the University of Toronto
And external collaborators from:
- Carleton University
- University of California, San Diego